Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice

Respiratory Medicine

Volumn 93, Issue 3, 1999, Pages 173-179

  Miravitlles, M ^a   Mayordomo, C ^b   Artes M ^c   Sanchez Agudo L ^b   Nicolau, F ^a   Segu J L ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Pharma Consult Services SA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; MUCOLYTIC AGENT; THEOPHYLLINE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG USE; FEMALE; GENERAL PRACTITIONER; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; ORAL DRUG ADMINISTRATION; OUTPATIENT CARE; PRESCRIPTION; PREVALENCE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; SPAIN;

EID: 0032992798     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(99)90004-5     Document Type: Article

References (23)

1. Higgins MW, Thorn T. Incidence, prevalence, and mortality: intra- and inter-county differences. In: Hensley MJ, Saunders NA, eds. Clinical Epidemiology of Chronic Obstructive Pulmonary Disease. New York: Marcel Dekker, 1990: 23-43.
2. Brotons B, Ferez JA, Sânchez-Toril F, Soriano S, Hernândez J, Belenguer JL. Prevalencia de la enfermedad obstructiva crônica y el asma. Estudio transversal (English abstract). Arch Bronchoneumol 1994; 30: 149-152.
3. Viejo JL, Miravitlles M, Gabriel R, Masa JF, Villasante C, Jiménez ÇA, Fernândez-Fau L, Sobradillo V. Prevalence of COPD in Spain. Results of the IBERPOC study. Eur Respir J1998; 12 (Suppl. 28): 233S.
4. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398-1420.
5. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: S77-S120.
6. Baiter MS, Hyland RH, Low DE, et al. Recommendations on the management of chronic bronchitis: a practical guide for Canadian physicians. Can Med Assoc J 1994; 151: 1-23.
7. Montemayor T, Alfajeme I, Escudeo C, Morera J, Sânchez-Agudo L. Normativa sobre diagnôstico y tratamiento de la enfermedad pulmonar obstructiva crônica. Arch Bronchoneumol 1996; 32: 285-301.
8. Huchon GJ, Gialdroni-Grassi G, Léophonte P, Manresa F, Schaberg T, Woodhead M. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. Eur Respir J 1996; 9: 1590-1595.
9. American Thoracic Society Statement. Snowbird Workshop on standardization of spirometry. Am Rev Respir Dis 1979; 119: 831-838.
10. Anthonisen NR, Manfreda J, Warren CPW, Hershfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
11. Kesten S, Chapman KR. Physician perceptions and management of COPD. Chest 1993; 104: 254-258.
12. Naderân Tona C. Encuesta de la actitud terapéutioa y de control de los medicos générales de las ABS de Barcelona, respecte a enfermedades obstructivas respiratorias (English abstract). A ten Primaria (Bare) 1994; 13: 112-115.
13. Jackevicius C, Joyce DP, Kesten S, Chapman KR. Prehospitalization inhaled corticosteroid use in patients with COPD and asthma. Chest 1997; 111: 296-302.
14. Ferguson GT, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med 1993; 328: 1017-1022.
15. Renwick DS, Connolly MJ. Prevalence and treatment of chronic airways obstruction in adults over the age of 45. Thorax 1996; 51: 164-168.
16. Jones PW, Bosh TK, in association with an international study group. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997; 155: 1283-1289.
17. Kerstjens HAM, Overbeek SE, Scheuten JP, Brand PLP, Postma DS, and the Dutch CNSLD Study Group. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV! during long-term inhaled corticosteroid treatment. Eur Respir J 1993; 6: 868-876.
18. Weiner P, Weiner M, Azgad Y, Zamir D. Inhaled budesonide therapy for patients with stable COPD, Chest 1995; 108: 1568-1571.
19. Sachs APE, Koëter GH, Groenier KH, van der Waaij D, Schiphuis J, Meyboom-de Jong B. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. Thorax 1995; 50: 758-763.
20. Thompson WH, Nielson CP, Carvalho P. Charan NB, Crowley JJ. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996; 154: 407-412.
21. Davey P, Rutherford D, Graham B, Lynch B, Malek M. Repeat consultations after antibiotic prescribing for respiratory infection: a study in one general practice. Br J Gen Pract 1994; 44: 509-513.
22. MacFarlane JT, Colville A, Guion A, MacFarlane RM, Rose DH. Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community. Lancet 1993; 341: 511-514.
23. Ball P, Harris JM. Lowson D, Tillotson G, Wilson R. Acute infective exacerbations of chronic bronchitis. Q J Mcd 1995; 88: 61-68.